January 2018 Volume 14, Issue 1

Volume 14, Issue 1 | January 2018

January 2018

In this Issue

Feature

Drug Discovery News Placeholder Image

SLAS2018 Show Preview: Where the life sciences community converges

San Diego plays host to this year’s International Conference and Exhibition of the Society for Laboratory Automation and Screening. Read more to find out what's happening so you know what to expect when you're there, or why you should consider attending this or future SLAS conferences.

Editor's Focus

Drug Discovery News Placeholder Image

Editor’s focus: What looks like outrage might be necessity

Companies, including pharmas and biotechs, do engage in greedy decisions at times, but does the high cost presented for a new gene therapy represent avarice or a need to recoup losses for bringing to market a powerful but still very new approach?

Commentary

Drug Discovery News Placeholder Image

Out of order: We are our stories

A Hollywood screenwriter, a marine biologist and a science journalist walk into a lecture hall...and suggest you should tell more stories

Discovery

Drug Discovery News Placeholder Image

AI aids efforts in ALS

IBM’s Watson validates discovery of five new genes linked to the neurodegenerative disease
Drug Discovery News Placeholder Image

Substance solubility

SPA could expedite drug development
Drug Discovery News Placeholder Image

Compugen and JHU chart a new course

Collaboration researches first-in-class cancer therapy
Drug Discovery News Placeholder Image

A new friend in AMIGO2?

Mount Sinai details the potential of transmembrane gene for halting melanoma growth

Research & Development

Drug Discovery News Placeholder Image

A GalXC far, far away

Collaboration to explore RNA interference therapeutics for liver disease
Drug Discovery News Placeholder Image

MicroRNAs and cancer

Salk Institute research illustrates how tumors outsmart immune response
Drug Discovery News Placeholder Image

Proud partnership

Collaboration between Shire and Rani will evaluate approach to oral delivery of factor therapy for patients with hemophilia
Drug Discovery News Placeholder Image

Oxford Genetics and MeiraGTx tackle AAVs

The partners hope to develop a new production system that offers better yields and robustness
Drug Discovery News Placeholder Image

Culturing the unculturable

Biomillenia leverages QIAGEN bioinformatics in microbiome-on-a-chip discovery of unculturable microbes

Clinical Trials

Drug Discovery News Placeholder Image

Novartis eyes nAMD

Results from Phase 3 studies support brolucizumab’s less-frequent dosing schedule
Drug Discovery News Placeholder Image

Cell replacement therapy

Companies collaborate in clinical trials of ex-vivo expanded cord blood stem cells
Drug Discovery News Placeholder Image

Clinical support for pGlu-Abeta targeting

Probiodrug to start Phase 2b clinical trial of PQ912 in Alzheimer’s
Drug Discovery News Placeholder Image

New angle on immunotherapy

Salk researchers get $2.5 million for pancreatic cancer trial involving vitamin D and Keytruda
Drug Discovery News Placeholder Image

More trials, more data sources, more problems

Tufts survey reveals that plans to use greater range of patient data in clinical trials also means a need to prepare for management challenges

Contract Services

Drug Discovery News Placeholder Image

A busy end to 2017

PPD’s Q4 includes awards, a new NIH contract and expanded service offerings
Drug Discovery News Placeholder Image

A fivefold increase in sales

ApconiX benefits from boost via pharma sector demand for drug safety expertise
Drug Discovery News Placeholder Image

Quotient Sciences acquires Pharmaterials

Move strengthens and expands formulation and manufacturing services footprint in the U.K.

Diagnostics

Drug Discovery News Placeholder Image

Extending the team-up against AD

Continuation of Probiodrug and Crossbeta partnership to identify Alzheimer’s biomarkers
Drug Discovery News Placeholder Image

A companion diagnostic with greater breadth

FDA approves FoundationOne CDx companion diagnostic test for multiple solid tumors
Drug Discovery News Placeholder Image

Predicting lupus flares?

Progentec completes first round of financing for $1.25 million

Preclinical

Drug Discovery News Placeholder Image

Dialing in on a new DMD target

Summit shares preclinical data supporting utrophin as a target for slowing muscular dystrophy progression
Drug Discovery News Placeholder Image

More answers on mavacamten

New research on drug elucidates successful HCM treatment mechanism
Drug Discovery News Placeholder Image

Hope for rare eye disease patients

NanoViricides presents ‘highly effective’ treatment for acute retinal necrosis
Drug Discovery News Placeholder Image

Telemetry device advances metabolic disease research

Crown Bioscience and Data Sciences International partner to use device for long-term blood glucose monitoring

Business & Government Policy

Drug Discovery News Placeholder Image

A ‘softer’ Brexit?

U.K. government’s narrow defeat on amendment in withdrawal bill could have wide impact
Drug Discovery News Placeholder Image

On the cutting edge

A roundup of instrumentation, software and other tools and technology news
Drug Discovery News Placeholder Image

Mallinckrodt to acquire Sucampo for $1.2 billion

Transaction expected to be immediately accretive thanks to Amitiza and other Sucampo assets
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue